176 related articles for article (PubMed ID: 15832772)
1. Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis.
Szturmowicz M; Tomkowski W; Fijalkowska A; Kupis W; Cieślik A; Demkow U; Langfort R; Wiechecka A; Orlowski T; Torbicki A
Int J Biol Markers; 2005; 20(1):43-9. PubMed ID: 15832772
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis.
Szturmowicz M; Tomkowski W; Fijalkowska A; Kupis W; Cieslik A; Demkow U; Langfort R; Wiechecka A; Orlowski T; Torbicki A
Int J Biol Markers; 2005; 20(1):43-49. PubMed ID: 28207101
[TBL] [Abstract][Full Text] [Related]
3. [Neoplastic pericarditis--the role of different diagnostic procedures].
Pawlak-Cieślik A; Szturmowicz M; Fijałkowska A; Tomkowski W; Kupis W; Langfort R; Demkow U; Wiechecka A; Orłowski T; Torbicki A
Pol Arch Med Wewn; 2006 Jan; 115(1):37-44. PubMed ID: 17278783
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of malignant pericarditis: a single centre experience.
Pawlak Cieślik A; Szturmowicz M; Fijałkowska A; Gątarek J; Gralec R; Błasińska-Przerwa K; Szczepulska-Wójcik E; Skoczylas A; Bilska A; Tomkowski W
Kardiol Pol; 2012; 70(11):1147-53. PubMed ID: 23180523
[TBL] [Abstract][Full Text] [Related]
5. The role of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) evaluation in pericardial fluid for the recognition of malignant pericarditis.
Szturmowicz M; Tomkowski W; Fijalkowska A; Burakowski J; Sakowicz A; Filipecki S
Int J Biol Markers; 1997; 12(3):96-101. PubMed ID: 9479590
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma.
Paganuzzi M; Onetto M; Marroni P; Filiberti R; Tassara E; Parodi S; Felletti R
Chest; 2001 Apr; 119(4):1138-42. PubMed ID: 11296181
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
Salama G; Miédougé M; Rouzaud P; Mauduyt MA; Pujazon MC; Vincent C; Carles P; Serre G
Br J Cancer; 1998; 77(3):472-6. PubMed ID: 9472646
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.
Ferrer J; Villarino MA; Encabo G; Felip E; Bermejo B; Vilà S; Orriols R
Cancer; 1999 Oct; 86(8):1488-95. PubMed ID: 10526277
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion.
Lai RS; Chen CC; Lee PC; Lu JY
Jpn J Clin Oncol; 1999 Sep; 29(9):421-4. PubMed ID: 10563194
[TBL] [Abstract][Full Text] [Related]
10. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigens in the pericardial fluid of patients with malignant pericarditis.
Tatsuta M; Yamamura H; Yamamoto R; Ichii M; Iishi H; Noguchi S
Oncology; 1984; 41(5):328-30. PubMed ID: 6472769
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.
Lee JH; Chang JH
Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of CYFRA 21-1 in malignant pleural fluids.
Satoh H; Sumi M; Yagyu H; Ishikawa H; Suyama T; Naitoh T; Saitoh T; Hasegawa S
Oncology; 1995; 52(3):211-4. PubMed ID: 7536317
[TBL] [Abstract][Full Text] [Related]
14. [Tumor markers in the assessment of malignant and benign pericardial effusion].
Karatolios K; Maisch B; Pankuweit S
Herz; 2011 Jun; 36(4):290-5. PubMed ID: 21491120
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic usefulness of selected tumor markers (CA125, CEA, CYFRA 21-1) in bronchoalveolar lavage fluid in patients with non-small cell lung cancer].
Dabrowska M; Grubek-Jaworska H; Domagała-Kulawik J; Bartoszewicz Z; Kondracka A; Krenke R; Nejman P; Chazan R
Pol Arch Med Wewn; 2004 Jun; 111(6):659-65. PubMed ID: 15508787
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of CYFRA 21-1 in malignant pleural effusion.
Dejsomritrutai W; Senawong S; Promkiamon B
Respirology; 2001 Sep; 6(3):213-6. PubMed ID: 11555379
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma.
Huang WW; Tsao SM; Lai CL; Su CC; Tseng CE
Pathology; 2010 Apr; 42(3):224-8. PubMed ID: 20350214
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
[TBL] [Abstract][Full Text] [Related]
19. The value of the new scoring system for predicting neoplastic pericarditis in the patients with large pericardial effusion.
Szturmowicz M; Pawlak-Cieślik A; Fijałkowska A; Gątarek J; Skoczylas A; Dybowska M; Błasińska-Przerwa K; Langfort R; Tomkowski W
Support Care Cancer; 2017 Aug; 25(8):2399-2403. PubMed ID: 28258502
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis.
Gu P; Huang G; Chen Y; Zhu C; Yuan J; Sheng S
J Clin Lab Anal; 2007; 21(6):398-405. PubMed ID: 18022924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
